Evidence map›Paper›PMID 32756510›Full record

ArticleJournal of clinical medicine2020

S-Detect Software vs. EU-TIRADS Classification: A Dual-Center Validation of Diagnostic Performance in Differentiation of Thyroid Nodules.

Ewelina Szczepanek-Parulska, Kosma Wolinski, Katarzyna Dobruch-Sobczak, Patrycja Antosik, Anna Ostalowska, Agnieszka Krauze, Bartosz Migda, Agnieszka Zylka, Malgorzata Lange-Ratajczak, Tomasz Banasiewicz and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Ewelina Szczepanek-ParulskaDepartment of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
Kosma WolinskiDepartment of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
Katarzyna Dobruch-SobczakRadiology Department II, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.ORCID 0000-0003-1470-4140
Patrycja AntosikDepartment of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.ORCID 0000-0001-7922-7467
Anna OstalowskaDepartment of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.ORCID 0000-0002-1723-6410
Agnieszka KrauzeDiagnostic Imaging Department, Medical University of Warsaw, 2nd Faculty of Medicine with the English Division and the Physiotherapy Division, 03-242 Warsaw, Poland.
Bartosz MigdaDiagnostic Imaging Department, Medical University of Warsaw, 2nd Faculty of Medicine with the English Division and the Physiotherapy Division, 03-242 Warsaw, Poland.ORCID 0000-0001-8308-8121
Agnieszka ZylkaDepartment of Oncological Endocrinology and Nuclear Medicine, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Malgorzata Lange-RatajczakDepartment of General, Endocrinological, and Oncological Surgery and Gastrointestinal Oncology, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
Tomasz BanasiewiczDepartment of General, Endocrinological, and Oncological Surgery and Gastrointestinal Oncology, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
Marek DedecjusDepartment of Oncological Endocrinology and Nuclear Medicine, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
Zbigniew AdamczewskiDepartment of Endocrinology and Metabolic Diseases, Medical University of Lodz, 90-419 Lodz, Poland.ORCID 0000-0001-8713-6936
Rafal Z SlapaDiagnostic Imaging Department, Medical University of Warsaw, 2nd Faculty of Medicine with the English Division and the Physiotherapy Division, 03-242 Warsaw, Poland.
Robert K MlosekDiagnostic Imaging Department, Medical University of Warsaw, 2nd Faculty of Medicine with the English Division and the Physiotherapy Division, 03-242 Warsaw, Poland.
Andrzej LewinskiDepartment of Endocrinology and Metabolic Diseases, Medical University of Lodz, 90-419 Lodz, Poland.ORCID 0000-0002-8748-3337
Marek RuchalaDepartment of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland.ORCID 0000-0002-6296-7220
Poznan University of Medical Sciences · PLMedical University of Warsaw · PLThe Maria Sklodowska-Curie National Research Institute of Oncology · PLMedical University of Lodz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computer-aided diagnosis (CAD) and other risk stratification systems may improve ultrasound image interpretation. This prospective study aimed to compare the diagnostic performance of CAD and the European Thyroid Imaging Reporting and Data System (EU-TIRADS) classification applied by physicians with S-Detect 2 software CAD based on Korean Thyroid Imaging Reporting and Data System (K-TIRADS) and combinations of both methods (MODELs 1 to 5). In all, 133 nodules from 88 patients referred to thyroidectomy with available histopathology or with unambiguous results of cytology were included. The S-Detect system, EU-TIRADS, and mixed MODELs 1-5 for the diagnosis of thyroid cancer showed a sensitivity of 89.4%, 90.9%, 84.9%, 95.5%, 93.9%, 78.9% and 93.9%; a specificity of 80.6%, 61.2%, 88.1%, 53.7%, 73.1%, 89.6% and 80.6%; a positive predictive value of 81.9%, 69.8%, 87.5%, 67%, 77.5%, 88.1% and 82.7%; a negative predictive value of 88.5%, 87.2%, 85.5%, 92.3%, 92.5%, 81.1% and 93.1%; and an accuracy of 85%, 75.9%, 86.5%, 74.4%, 83.5%, 84.2%, and 87.2%, respectively. Comparison showed superiority of the similar MODELs 1 and 5 over other mixed models as well as EU-TIRADS and S-Detect used alone (

Indexed as

computer-aided diagnosisEU-TIRADSS-Detectthyroid cancerthyroid nodulesultrasound

Identifiers

PMID32756510
PMCPMC7464710
OpenAlexW3047455554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.